首页 | 本学科首页   官方微博 | 高级检索  
     


Favourable outcomes of 177Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours
Authors:Raghava Kashyap  Michael S. Hofman  Michael Michael  Grace Kong  Timothy Akhurst  Peter Eu  Diana Zannino  Rodney J. Hicks
Affiliation:1. Centre for Cancer Imaging, Peter MacCallum Cancer Center, St Andrews Place, 3002, Melbourne, Australia
3. Neuroendocrine Tumour Service, Peter MacCallum Cancer Centre, Melbourne, Australia
2. Department of Medicine, University of Medicine, Melbourne, Australia
4. Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia
6. The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
5. Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号